Publications:

---

Case report: BRAF A598-T599insV mutation as a potential resistance mechanism to alectinib in ALK-rearranged lung adenocarcinoma.

Frontiers In Oncology

Pasau, Thomas T; Wauters, Els E; Wauters, Isabelle I; Duplaquet, Fabrice F; Pirard, Lionel L; Pop-Stanciu, Claudia C; D'Haene, Nicky N; Dupont, Michael M; Vander Borght, Thierry T; Rondelet, Benoît B; Ocak, Sebahat S

Publication Date: 2022

Variant appearance in text: BRAF: G15V

PubMed Link: 36419902

Variant Present in the following documents:

• Main text
• fonc-12-985446.pdf

View BVdb publication page

---

Current Knowledge about Mechanisms of Drug Resistance against ALK Inhibitors in Non-Small Cell Lung Cancer.

Cancers

Smolle, Elisabeth E; Taucher, Valentin V; Lindenmann, Joerg J; Jost, Philipp J PJ; Pichler, Martin M

Publication Date: 2021-02-09

Variant appearance in text: BRAF: G15V

PubMed Link: 33572278

Variant Present in the following documents:

• Main text
• cancers-13-00699.pdf

View BVdb publication page

---

Acquired resistance to targeted therapies in NSCLC: Updates and evolving insights.

Pharmacology & Therapeutics

Meador, Catherine B CB; Hata, Aaron N AN

Publication Date: 2020-06

Variant appearance in text: BRAF: G15V

PubMed Link: 32151666

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates.

Nature Communications

Kis, Olena O; Kaedbey, Rayan R; Chow, Signy S; Danesh, Arnavaz A; Dowar, Mark M; Li, Tiantian T; Li, Zhihua Z; Liu, Jessica J; Mansour, Mark M; Masih-Khan, Esther E; Zhang, Tong T; Bratman, Scott V SV; Oza, Amit M AM; Kamel-Reid, Suzanne S; Trudel, Suzanne S; Pugh, Trevor J TJ

Publication Date: 2017-05-11

Variant appearance in text: BRAF: 44G>T

PubMed Link: 28492226

Variant Present in the following documents:

• ncomms15086-s3.xlsx, sheet 1

View BVdb publication page

---

The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.

Genome Medicine

Garofalo, Andrea A; Sholl, Lynette L; Reardon, Brendan B; Taylor-Weiner, Amaro A; Amin-Mansour, Ali A; Miao, Diana D; Liu, David D; Oliver, Nelly N; MacConaill, Laura L; Ducar, Matthew M; Rojas-Rudilla, Vanesa V; Giannakis, Marios M; Ghazani, Arezou A; Gray, Stacy S; Janne, Pasi P; Garber, Judy J; Joffe, Steve S; Lindeman, Neal N; Wagle, Nikhil N; Garraway, Levi A LA; Van Allen, Eliezer M EM

Publication Date: 2016-07-26

Variant appearance in text: BRAF: 44G>T

PubMed Link: 27460824

Variant Present in the following documents:

• 13073_2016_333_MOESM5_ESM.xlsx, sheet 1

View BVdb publication page

---

Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer.

Cancer Discovery

Gainor, Justin F JF; Dardaei, Leila L; Yoda, Satoshi S; Friboulet, Luc L; Leshchiner, Ignaty I; Katayama, Ryohei R; Dagogo-Jack, Ibiayi I; Gadgeel, Shirish S; Schultz, Katherine K; Singh, Manrose M; Chin, Emily E; Parks, Melissa M; Lee, Dana D; DiCecca, Richard H RH; Lockerman, Elizabeth E; Huynh, Tiffany T; Logan, Jennifer J; Ritterhouse, Lauren L LL; Le, Long P LP; Muniappan, Ashok A; Digumarthy, Subba S; Channick, Colleen C; Keyes, Colleen C; Getz, Gad G; Dias-Santagata, Dora D; Heist, Rebecca S RS; Lennerz, Jochen J; Sequist, Lecia V LV; Benes, Cyril H CH; Iafrate, A John AJ; Mino-Kenudson, Mari M; Engelman, Jeffrey A JA; Shaw, Alice T AT

Publication Date: 2016-10

Variant appearance in text: BRAF: G15V

PubMed Link: 27432227

Variant Present in the following documents:

• Main text

View BVdb publication page

---